Skip to main content

The Wistar Institute

|

Wistar Scientists Discover New Immunosuppressive Mechanism in Brain Cancer

PHILADELPHIA — (May 3, 2024) — The Wistar Institute assistant professor Filippo Veglia, Ph.D., and team, have discovered a key mechanism of how glioblastoma — a serious and often fatal brain cancer — suppresses the immune system so that the tumor ca…
Read more
|

The Wistar Institute and Collaborators Celebrate Two New Cohorts of Philly’s Life Science Workforce

University City, Philadelphia may have been quieter than usual with so many taking spring breaks, but March was a busy month for The Wistar Institute’s Hubert J.P. Schoemaker Education and Training Center: not one but two cohorts of the Institute’s…
Read more
|

Promising Personalized Approach to Liver Cancer Therapy Made Possible by DNA-based Neoantigen Research Designed at The Wistar Institute

PHILADELPHIA — (Tuesday, April 30, 2024) — Hepatocellular carcinoma (HCC), or liver cancer, is an aggressive malignancy with limited treatment options. An immunologically cold cancer — meaning the tumors can effectively hide themselves from the immu…
Read more
|

“Immunology is a Battlefield”: Wistar’s Dr. Nan Zhang on Creativity and Curiosity in Science

Dr. Nan Zhang, Ph.D., is an Assistant Professor in the Immunology, Microenvironment and Metastasis Program at the Ellen and Ronald Caplan Cancer Center. He studies the role of immune cells called macrophages in tumor growth and metastasis in the abd…
Read more
|

Wistar Scientists Start New Conference on Foundational RNA Research

Back from hosting the first-ever Genome Regulation through RNA Conference in Cancun, Mexico, Wistar faculty members Alessandro Gardini, Ph.D., and Kavitha Sarma, Ph.D., give us the inside scoop on what it was like to host a scientific meeting from s…
Read more
|

Wistar Scientists Identify Pro-aging ‘Sugar Signature’ in the Blood of People Living with HIV

PHILADELPHIA — (April 10, 2024) — The Wistar Institute’s associate professor Mohamed Abdel-Mohsen, Ph.D., along with his team and collaborators, has identified sugar abnormalities in the blood that may promote biological aging and inflammation in pe…
Read more
|

Early-Stage Discovery: How Wistar’s Genomics Facility Drives Wistar Science

Meet Sonali Majumdar, M.S., managing director of The Wistar Institute Genomics Facility, a hub that turns biological material into the data scientists need. Ms. Majumdar discussed the ins and outs of genomics technology and how Wistar Science depend…
Read more
|

Wistar Scientists Explore Importance of Microglia Marker in Metastasized Brain Tumor Microenvironment

PHILADELPHIA—(Mar. 28, 2024)— The Wistar Institute’s Qing Chen, M.D., Ph.D., assistant professor in the Immunology, Microenvironment and Metastasis Program at the Ellen and Ronald Caplan Cancer Center, has discovered certain immune cells in the brai…
Read more
|

Formulating a love for science

Kensington Health Sciences Academy students get hands-on experience and exposure to Wistar Science Standing in The Wistar Institute’s state-of-the-art training lab, a small group of 12 students gathered quietly around a large digital display project…
Read more
|

Wistar in the News: Inquirer story on new Wistar-PCOM Cancer Biology Ph.D. Program

The Wistar Institute was featured in The Philadelphia Inquirer for the launch its new Cancer Biology Ph.D. Program with Philadelphia College of Osteopathic Medicine. Reporter Sarah Gantz detailed how the jointly run Ph.D. program will offe…
Read more